title: Severe psychotic disorder and agranulocytosis--a therapeutic dilemma.
authors.forename: R
authors.initials: R
authors.lastname: Borbé
authors.forename: K
authors.initials: K
authors.lastname: Weisel
authors.forename: U J H
authors.initials: UJ
authors.lastname: Sachs
authors.forename: T
authors.initials: T
authors.lastname: Steinert
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D005500:Follow-Up Studies; D006098:Granulocytes / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine